Kronos Bio (KRON) has released an update to notify the public and investors about its officers.
On January 24, 2024, Kronos Bio, Inc. reached mutual agreements to terminate the employment of both Jorge DiMartino, M.D., Ph.D., Chief Medical Officer, and Barbara Kosacz, J.D., Chief Operating Officer and General Counsel, effective February 16, 2024. Additionally, the company entered into a Separation Agreement with Dr. DiMartino, classifying his termination as a “Covered Termination,” which allows for a lump sum severance under the company’s Severance Plan, and also discusses a potential consultancy role post-termination.
For further insights into KRON corporate activity, check out TipRanks’ Insiders Trading Activity page.
